title: MRI measures should be a primary outcome endpoint in phase III randomized controlled trials in multiple sclerosis: no.
authors.affiliation: Nuffield Department of Clinical Neurosciences, John Radcliffe Hospital, Oxford, UK.
authors.forename: George C
authors.initials: GC
authors.lastname: Ebers
mesh_terms: D006801:Humans; D008279:Magnetic Resonance Imaging; D009103:Multiple Sclerosis / Q000473:pathology*; D016032:Randomized Controlled Trials as Topic